Shoulder Innovations price target raised to $19 from $18 at Piper Sandler

Piper Sandler analyst Matt O’Brien raised the firm’s price target on Shoulder Innovations (SI) to $19 from $18 and keeps an Overweight rating on the shares. Over the next year, Shoulder Innovations should be launching three new products that would expand its addressable market by $200M-plus, the firm notes. Once these products hit the market, the company will have a comprehensive portfolio to address nearly all of surgeons’ needs. Piper expects these product launches to drive higher utilization among the existing core/contender surgeon base, amounting to 180 bps-260 bps of potential revenue upside versus its model in 2026-2028.